Minlin Jiang

1.9k total citations · 2 hit papers
29 papers, 1.2k citations indexed

About

Minlin Jiang is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Minlin Jiang has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Minlin Jiang's work include Cancer Immunotherapy and Biomarkers (10 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Minlin Jiang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Cancer Genomics and Diagnostics (8 papers) and Lung Cancer Treatments and Mutations (6 papers). Minlin Jiang collaborates with scholars based in China, United States and Canada. Minlin Jiang's co-authors include Yayi He, Sha Zhao, Caicun Zhou, Wei Li, Lei Wang, Bin Chen, Peixin Chen, Yu Liu, Lingyun Ye and Hao Wang and has published in prestigious journals such as The Journal of Infectious Diseases, Seminars in Cancer Biology and Theranostics.

In The Last Decade

Minlin Jiang

28 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

cGAS-STING, an important pathway in cancer immunotherapy

2020 432 citations Minlin Jiang, Peixin Chen et al. Journal of Hematology & Oncology profile →
Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy

2021 203 citations Minlin Jiang, Keyi Jia et al. Acta Pharmaceutica Sinica B profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Minlin Jiang China	12	574	453	410	288	246	29	1.2k
Caicun Zhou China	20	693 1.2×	802 1.8×	846 2.1×	279 1.0×	251 1.0×	49	1.7k
Ayman Oweida United States	19	336 0.6×	423 0.9×	694 1.7×	245 0.9×	129 0.5×	46	1.3k
Eileen E. Parkes United Kingdom	12	441 0.8×	435 1.0×	541 1.3×	157 0.5×	149 0.6×	36	1.0k
Navid Sobhani Italy	21	556 1.0×	294 0.6×	607 1.5×	416 1.4×	249 1.0×	58	1.3k
Amandine Alard United States	10	576 1.0×	724 1.6×	851 2.1×	315 1.1×	169 0.7×	13	1.6k
Alex Chehrazi‐Raffle United States	11	374 0.7×	461 1.0×	869 2.1×	331 1.1×	171 0.7×	64	1.3k
Saied Mirshahidi United States	21	906 1.6×	370 0.8×	300 0.7×	157 0.5×	463 1.9×	66	1.5k
Tala Shekarian Switzerland	11	341 0.6×	694 1.5×	675 1.6×	154 0.5×	116 0.5×	15	1.3k
Tao Shi China	16	419 0.7×	490 1.1×	548 1.3×	170 0.6×	140 0.6×	39	1.2k
Khashayar Esfahani Canada	11	374 0.7×	430 0.9×	741 1.8×	203 0.7×	112 0.5×	37	1.3k

Countries citing papers authored by Minlin Jiang

Since Specialization

Citations

This map shows the geographic impact of Minlin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minlin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minlin Jiang more than expected).

Fields of papers citing papers by Minlin Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minlin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minlin Jiang. The network helps show where Minlin Jiang may publish in the future.

Co-authorship network of co-authors of Minlin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Minlin Jiang. A scholar is included among the top collaborators of Minlin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minlin Jiang. Minlin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hu, Congli, et al.. (2025). IL‐15 Superagonist SHR‐1501 Enhances Immune Responses in Lung Cancer by Modulating Tumor Microenvironment. The Clinical Respiratory Journal. 19(8). e70117–e70117.

Liu, Yunhuan, Yong Yu, Congli Hu, et al.. (2025). ZEB2 upregulation modulates the polarization of TAMs toward the immunosuppressive state in EGFR-TKI-resistant NSCLC. Cancer Drug Resistance. 8. 25–25. 1 indexed citations

Jiang, Minlin, Hong Wu, Yiqiang Liu, et al.. (2024). SIRPG expression positively associates with an inflamed tumor microenvironment and response to PD-1 blockade. Cancer Immunology Immunotherapy. 73(8). 147–147. 4 indexed citations

Jiang, Minlin, Jiya Sun, Congli Hu, et al.. (2024). A tumor cornification and immune-infiltration-based scheme for anti-PD-1 plus chemotherapy response in advanced squamous cell lung carcinoma. Med. 6(2). 100516–100516. 1 indexed citations

Wang, Lei, Zheng Zhang, Minlin Jiang, et al.. (2023). Comparison of the somatic genomic landscape between central- and peripheral-type non-small cell lung cancer. Lung Cancer. 187. 107439–107439. 1 indexed citations

Liu, Yu‐Hsuan, et al.. (2023). Regulatory considerations for generic products of non-biological complex drugs. Journal of Food and Drug Analysis. 31(1). 20–31. 6 indexed citations

Zhu, Liang, Peixin Chen, Hao Wang, et al.. (2022). Analysis of prognostic and therapeutic values of drug resistance-related genes in the lung cancer microenvironment. Translational Cancer Research. 11(2). 339–357. 7 indexed citations

Wang, Hao, Haoyue Guo, Chenglong Sun, et al.. (2021). Single-Cell Sequencing, an Advanced Technology in Lung Cancer Research. OncoTargets and Therapy. Volume 14. 1895–1909. 10 indexed citations

Jiang, Minlin, Keyi Jia, Lei Wang, et al.. (2021). Alterations of DNA damage response pathway: Biomarker and therapeutic strategy for cancer immunotherapy. Acta Pharmaceutica Sinica B. 11(10). 2983–2994. 203 indexed citations breakdown →

10.

Jiang, Minlin, Yi Xu, Peixin Chen, et al.. (2021). Curative efficacy might be an early predictor of prognosis in patients with small cell lung cancer treated with 2 cycles of platinum-based first-line chemotherapy. Journal of Thoracic Disease. 13(2). 1205–1214. 2 indexed citations

11.

Wang, Hao, Shanhao Chen, Chunyan Wu, et al.. (2021). Tumor Mutation Burden and Differentially Mutated Genes Among Immune Phenotypes in Patients with Lung Adenocarcinoma. OncoTargets and Therapy. Volume 14. 2953–2965. 9 indexed citations

12.

Dai, Jiawei, Minlin Jiang, Kan He, et al.. (2021). DNA Damage Response and Repair Gene Alterations Increase Tumor Mutational Burden and Promote Poor Prognosis of Advanced Lung Cancer. Frontiers in Oncology. 11. 708294–708294. 23 indexed citations

13.

He, Yayi, Linsong Chen, Lishu Zhao, et al.. (2021). Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC. Theranostics. 11(14). 7092–7109. 11 indexed citations

14.

Guo, Haoyue, Lishu Zhao, Junjie Zhu, et al.. (2021). Microbes in lung cancer initiation, treatment, and outcome: Boon or bane?. Seminars in Cancer Biology. 86(Pt 2). 1190–1206. 30 indexed citations

15.

Zhang, Xuehan, Haoyue Guo, Yu Liu, et al.. (2021). Research progress on the molecular mechanisms of hepatic metastasis in lung cancer: a narrative review. Annals of Palliative Medicine. 10(4). 4806–4822. 12 indexed citations

16.

Wang, Boyuan, Haoyue Guo, Yü Liu, et al.. (2021). Collection on reports of molecules linked to epithelial-mesenchymal transition in the process of treating metastasizing cancer: a narrative review. Annals of Translational Medicine. 9(11). 946–946. 6 indexed citations

17.

Deng, Juan, Xiaoxia Chen, Yu Liu, et al.. (2020). Hypoproteinemia being a manifestation of immunotherapy-related liver dysfunction. Annals of Translational Medicine. 8(14). 889–889. 3 indexed citations

18.

Jiang, Minlin, et al.. (2020). What is the efficacy of gentamicin on the incidence of vertigo attacks and hearing in patients with Meniere's disease compared with steroids? A meta-analysis. Journal of Neurology. 268(10). 3717–3727. 11 indexed citations

19.

Jiang, Minlin, Peixin Chen, Lei Wang, et al.. (2020). cGAS-STING, an important pathway in cancer immunotherapy. Journal of Hematology & Oncology. 13(1). 81–81. 432 indexed citations breakdown →

20.

Jiang, Minlin, Keyi Jia, Lei Wang, et al.. (2020). Alterations of DNA damage repair in cancer: from mechanisms to applications. Annals of Translational Medicine. 8(24). 1685–1685. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact